4//SEC Filing
Ehrlich Christopher B 4
Accession 0001213900-25-021180
CIK 0001870404other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:10 PM ET
Size
5.7 KB
Accession
0001213900-25-021180
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-03-04+119,486→ 119,486 totalExercise: $1.43Exp: 2035-03-03→ Common Stock (119,486 underlying)
Footnotes (1)
- [F1]Represents the 50% time-based portion of an award of options to purchase 238,971 shares, vesting on the nine month anniversary of the grant date, with the remaining portion subject to performance conditions.
Documents
Issuer
CERO THERAPEUTICS HOLDINGS, INC.
CIK 0001870404
Entity typeother
Related Parties
1- filerCIK 0001293973
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:10 PM ET
- Size
- 5.7 KB